Vous devez tre connect pour publier un avis.
Additionally, factors related to clinical treatmentsuch as the type of GLP-1RAs, dosage, combination therapy, and duration of treatmenthave exhibited diverse impacts with respect to cancer risk
You might experience: Mild digestive discomfort Headaches Stomach cramps or bloating Allergic responses Breathing difficulties (in rare cases)
Nature Scientific Reports 2016 comparative study showed GHK-Cu produced no cytotoxicity to human keratinocytes at concentrations up to 5,800 M over 72 hours and did not induce inflammatory biomarkers unlike other copper compounds
Efpeglenatide, an exendin 4-based molecule, also showed a significant reduction in major adverse cardiovascular events (7.0% vs
Understanding these risks can help you use both substances safely